© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
Study Reveals Major Gaps in Thyroid Screening During Pregnancy
May 18th 2025
Researchers report an alarming number of missed opportunities to screen pregnant individuals for thyroid disease, including among women with a history of the condition.
Joy Baker, MD: Understanding Patient Language in PPD Screening
May 17th 2025
ACOG 2025: Dr Baker shares how language can help create a trusting space for patients to speak openly about postpartum depression.
Postpartum Depression and the Missed Hand-Off to Primary Care
May 17th 2025
ACOG 2025: Joy Baker, MD, called for stronger cross-specialty collaboration to address maternal mental health after birth.
ACOG 2025: Steven Fleischman, MD, Inaugurated as 76th President, Urges New Fellows to Lead with Purpose
May 17th 2025
Steven Fleischman, MD, was inaugurated as ACOG’s 76th president, urging new fellows to lead with purpose and recognize their value in women’s health care.
Primary Care Falls Short in Managing Adolescent Heavy Menstrual Bleeding, Researchers Warn
May 17th 2025
Fewer than half of females who experienced heavy menstrual bleeding were given hormonal treatment, and far fewer were referred to gynecology, authors reported.
GLP1-RAs Superior to Metformin for CVD Risk Reduction in Women with PCOS, Large Study Finds
May 17th 2025
The findings support the potential cardiovascular advantages of the GLP-1RA class in women with PCOS, a population already at increased cardiometabolic risk.
Study Identifies 6 Components of a Pregnancy Exercise Program that Reduce Risk of Poor Perinatal Outcomes
May 17th 2025
While exercise is beneficial during pregnancy and ACOG recommends 150 mins/week, this is the first study to examine benefits of specific regimen elements on their own.
Fezolinetant Demonstrates Reduced Waist Circumference, Body Roundness and Stable Weight and BMI in 52-Week Pooled Analysis of Phase 3 SKYLIGHT Trials
May 17th 2025
Postmenopausal women taking fezolinetant experienced positive changes in body fat distribution, increases in which are known to increase risks of cardiometabolic disease.
ACOG 2025: Poster Highlights for Primary Care
May 16th 2025
Details on 12 key abstracts with clinical relevance for primary care, from menopause management to PPD screening and HPV testing.
Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows
May 16th 2025
Elinzanetant reduced VMS frequency and intensity, and improved sleep and quality of life, according to the meta-analysis to be presented at the ACOG 2025 meeting.